Abstract:Background: Osteosarcoma is a malignant tumor originating from mesenchymal bone tissue, characterized by high malignancy and poor prognosis. Despite progress in comprehensive treatment approaches, the five-year survival rate remains largely unchanged, highlighting the need to clarify its underlying mechanisms and discover new therapeutic targets. Methods: This study utilized RNA sequencing data from multiple public databases, encompassing osteosarcoma samples and healthy controls, along with single-cell RNA sequencing data. Various methods were utilized, such as differential expression analysis of genes, analysis of metabolic pathways, and weighted gene co-expression network analysis (WGCNA), to pinpoint crucial genes. Using this list of genes, we developed and validated a prognostic model that incorporated risk signatures, and we evaluated the effectiveness of the model through survival analysis, immune cell infiltration examination, and drug sensitivity evaluation. Results: We analyzed gene expression and metabolic pathways in nine samples using single-cell sequencing data. Initially, we performed quality control and clustering, identifying 21 statistically significant cell subpopulations. Metabolic analyses of these subpopulations revealed heterogeneous activation of metabolic pathways. Focusing on the osteoblastic cell subpopulation, we further subdivided it into six groups and examined their gene expression and differentiation capabilities. Differential expression and enrichment analyses indicated that tumor tissues were enriched in cytoskeletal and structural pathways. Through WGCNA, we identified core genes negatively correlated with four highly activated metabolic pathways. Using osteosarcoma patient data, we developed a risk signature model that demonstrated robust prognostic predictions across three independent cohorts. Ultimately, we performed a thorough examination of the model, which encompassed clinical and pathological characteristics, enrichment analysis, pathways associated with cancer markers, and scores of immune infiltration, highlighting notable and complex disparities between high-risk and low-risk populations. Conclusion: This research clarifies the molecular mechanisms and metabolic features associated with osteosarcoma and how they relate to patient outcomes, offering novel perspectives and approaches for targeted therapy and prognostic assessment in osteosarcoma.

Establishment and Characteristics of Two Syngeneic Human Osteosarcoma Cell Lines from Primary Tumor and Skip Metastases

Biological Behaviors of Two Novel Syngeneic Human Osteosarcoma Cell Lines

Establishment and Characterization of a Highly Metastatic Human Osteosarcoma Cell Line from Osteosarcoma Lung Metastases.

Establishment and Characterization of a New Highly Metastatic Human Osteosarcoma Cell Line Derived from Saos2.

Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials

Establishment and Characterization of a Novel Osteosarcoma Cell Line: CHOS

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Establishment and Biological Characters of a Human Osteosarcoma Cell Line SOSP-9607

Establishment and characterization of a novel human osteosarcoma cell line for spontaneous pulmonary metastasis research in vivo

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma

Establishment of an Orthotopic Transplantation Model of Human Osteosarcoma and a Study of Its Biological Behavior

Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1)

An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis

Gene Expression Profiles Of Human Osteosarcoma Cell Sublines With Different Pulmonary Metastatic Potentials

Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma

Establishment and Characterization of a Patient-Derived Metastatic Extraskeletal Ewing Sarcoma Cell Line ES-ZSS-1

Relationship between oncogenicity of human osteosarcoma cells and clinical prognosis

Unveiling Cellular Traits of Osteosarcoma Cancer Stem Cells via Bulk and Single-Cell RNA-Sequencing Analysis

Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein

Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis